We are live on ! Find out more
PHVS icon

Pharvaris

110 hedge funds and large institutions have $1.66B invested in Pharvaris in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 35 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

4% more funds holding

Funds holding: 106110 (+4)

2% more capital invested

Capital invested by funds: $1.64B → $1.66B (+$26.4M)

0% more funds holding in top 10

Funds holding in top 10: 1212 (0)

3% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 35

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.75M

Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
1.35%
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
11
Increased
34
Reduced
35
Closed
6
Calls
Puts
$2.75M
Net Calls
-$2.75M
Net Calls Change
-$726K

PHVS Hedge Fund Activity: Q1 2026 in Review

110 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q1 2026, worth a combined $1.66B — up 1.6% from $1.64B a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new PHVS positions and 6 closed out — a net gain of 5 holders — while 34 added to existing stakes and 35 trimmed.

The largest buyer was Polar Capital Holdings, adding an estimated $14.5M. The largest seller was Octagon Capital Advisors, cutting an estimated $13.5M.

  • 110 institutional investors held Pharvaris (PHVS) as of Q1 2026, up from 106 in Q4 2025.
  • Funds reported $1.66B of Pharvaris stock for Q1 2026, up 1.6% quarter-over-quarter.
  • 11 funds opened new Pharvaris positions in Q1 2026 and 6 closed out, a net change of +5 holders.
  • The largest Pharvaris buyer in Q1 2026 was Polar Capital Holdings, an estimated $14.5M added.
  • The largest Pharvaris seller in Q1 2026 was Octagon Capital Advisors, an estimated $13.5M sold.

Based on aggregated 13F filings for Q1 2026.